EW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally...

Stats
Today's Volume	4.61M
Average Volume	3.15M
Market Cap	52.36B
EPS	$0 ( 2024-04-25 )
Next earnings date	( $0.700 ) 2024-07-24
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	37.45
ATR14	$0.0580 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-30	Zovighian Bernard J	Sell	8 617	Common Stock
2024-05-21	Ullem Scott B.	Sell	5 625	Employee Stock Option (Right to Acquire)
2024-05-21	Ullem Scott B.	Buy	5 625	Common Stock
2024-05-21	Ullem Scott B.	Sell	5 625	Common Stock
2024-05-11	Sellers Robert W.a.	Sell	229	Common Stock

INSIDER POWER
74.63
Last 99 transactions
Buy: 760 084 \| Sell: 110 077

Volume Correlation

Long: 0.71 (moderate)

Short: 0.56 (weak)

Signal:(87.282) Neutral

Edwards Lifesciences Corp Correlation

10 Most Positive Correlations
SAP	0.923
GWW	0.922
DECK	0.918
PHDG	0.911
DYN	0.91
PWB	0.91
JQUA	0.91
TWN	0.908
RPG	0.906
MMLG	0.906

10 Most Negative Correlations
SRFM	-0.951
SPHR	-0.938
PSQH	-0.932
GDV-PH	-0.93
GDV-PK	-0.926
RIV-PA	-0.924
FBIN	-0.923
MBC	-0.922
SCE-PG	-0.921
BYON	-0.918

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Edwards Lifesciences Corp Correlation - Currency/Commodity

-0.36
( neutral )

-0.67
( moderate negative )

0.00
( neutral )

0.19
( neutral )

0.16
( neutral )

Edwards Lifesciences Corp Financials

Annual	2023
Revenue:	$6.00B
Gross Profit:	$4.63B (77.02 %)
EPS:	$2.31

FY	2023
Revenue:	$6.00B
Gross Profit:	$4.63B (77.02 %)
EPS:	$2.31

FY	2022
Revenue:	$5.38B
Gross Profit:	$4.30B (79.93 %)
EPS:	$2.46

FY	2021
Revenue:	$5.23B
Gross Profit:	$3.98B (76.13 %)
EPS:	$2.41

Financial Reports:

No articles found.

Edwards Lifesciences Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.